clinical colorectal-cancer 
STAT
MARCH 13, 2024
Doctors have been eagerly waiting for data on Guardant Health’s new blood-based colorectal cancer screening test, the Shield test. The hope has been that Guardant would be able to achieve an elusive goal in colorectal cancer screening: catch incipient or early colorectal cancer using nothing more than two vials of blood.
World Pharma News
FEBRUARY 13, 2024
New research from global health system Cleveland Clinic has mapped changes in tumor-related bacteria to uncover potential new strategies to combat the rise of young-onset colorectal cancer (CRC) in people under the age of 50.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 10, 2023
Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands of colonoscopies a year, seeking and destroying precancerous polyps. It’s a practically surefire way to prevent colorectal cancer, but an unpleasant experience for patients.
STAT
OCTOBER 9, 2022
If everyone would get the screening just once a decade, clinicians believed it could practically make colorectal cancer “extinct,” said Michael Bretthauer, a gastroenterologist and researcher in Norway. But new results from a clinical trial that he led throw confidence in colonoscopy’s dominance into doubt.
STAT
JULY 24, 2023
Further testing over the next couple of weeks clarified the cause: Gosline had stage 4 colorectal cancer, which had spread to his liver. That’s “the very hard question that none of us really know the answer to,” said Timothy Rebbeck, professor of cancer prevention at the Harvard T.H.
Express Pharma
JANUARY 18, 2024
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancer, announced the selection of the PDC*neo+ project for funding by the Walloon region and BioWin, the health cluster for Wallonia.
Pharmaceutical Technology
DECEMBER 6, 2023
IGM will lay off 22% of its staff and suspend four clinical activities to advance autoimmune diseases and colorectal cancer programmes.
Expert insights. Personalized for you.
318 
Let's personalize your content